OBLN - オバロン・セラピュ―ティクス （Obalon Therapeutics Inc.） オバロン・セラピュ―ティクスOBLNのチャート
OBLNの企業情報
| symbol | OBLN |
|---|---|
| 会社名 | Obalon Therapeutics Inc （オバロン・セラピュ―ティクス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 オバロン･セラピューティクス(Obalon Therapeutics Inc)は体重減少を促進することによって肥満を治療する医療機器の開発･商品化に集中する商業ステージの医療機器会社である。同社の製品オーバロン･バルーン･システムは肥満患者の体重減少を促進する飲み込めるガス充填胃内バルーンである。オーバロン･バルーン･システムは中強度食品･行動調整プログラムの付属物として使用される。全部のバルーンは最初のバルーンの設置後6ヶ月で除去される。オーバロン･バルーン･システムは患者の解剖変更または手術要求なしに患者･医者に可逆的･繰り返し可能な体重減少ソリューションを提供することを目的とする。同社はスマート･トライアルと称される米国ピボタル臨床試験の結果に基づくオーバロン･バルーン･システムで製造販売承認(PMA)を取得した。 オバロン・セラピュ―ティクスは米国の医療機器メ―カ―。主に肥満解消を目的とした医療装置を開発・製造・販売する。同社の「オバロン・バル―ン・システム」は、ガス入りカプセルを飲み下すことにより胃内容積を占有し、食欲減退を促し体重減少に導く、患者への負担の少ない治療方法である。本社はカリフォルニア州カ―ルスバッド。 Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. |
| 本社所在地 | 5421 Avenida Encinas Suite F Carlsbad CA 92008 USA |
| 代表者氏名 | Kim P Kamdar キム・P・カムダール |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 858-480-2400 |
| 設立年月日 | 39448 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2016年 |
| 従業員数 | 137人 |
| url | www.obalon.com |
| nasdaq_url | https://www.nasdaq.com/symbol/obln |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -40.19200 |
| 終値（lastsale） | 2.14 |
| 時価総額（marketcap） | 49830349.4 |
| 時価総額 | 時価総額（百万ドル） 45.87186 |
| 売上高 | 売上高（百万ドル） 10.55700 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 30.60786 |
| 当期純利益 | 当期純利益（百万ドル） -41.16900 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Obalon Therapeutics Inc revenues increased 19% to $4.1M. Net loss increased 41% to $21.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling general and administrative - B increase of 39% to $15.2M (expense) Stock-based Compensation in SGA increase from $829K to $2M (expense). |
OBLNのテクニカル分析
OBLNのニュース
Active Stock Evaluation: Luokung Technology Corp. (NASDAQ:LKCO), Obalon Therapeutics, Inc. (NASDAQ:OBLN) 2021/06/23 20:57:02 Stock Equity
Luokung Technology Corp. (NASDAQ:LKCO) with the stream of 5.53% also noticed, India Obalon Therapeutics, Inc. (NASDAQ:OBLN) encountered a rapid change of 0.00% in the last hour of Wednesdays trading session. The post Active Stock Evaluation: Luokung Technology Corp. (NASDAQ:LKCO), Obalon Therapeutics, Inc. (NASDAQ:OBLN) appeared first on Stocks Equity .
ReShape Lifesciences (RSLS.Q) Completes Merger with Obalon Therapeutics 2021/06/16 17:46:19 Equity Guru
ReShape Lifesciences (RSLS.Q), a global weight-loss solutions leaders, announced today that it has completed its previously announced merger with Obalon Therapeutics, a vertically integrated medical technology company focused on developing and marketing medical devices. As a Nasdaq listed company, ReShape is poised to take advantage of the numerous benefits that accompany this new status, including [] The post ReShape Lifesciences (RSLS.Q) Completes Merger with Obalon Therapeutics appeared first on Equity.Guru .
ReShape Lifesciences Inc.: ReShape Lifesciences Completes Merger with Obalon Therapeutics 2021/06/16 11:32:00 FinanzNachrichten
Shares of ReShape Lifesciences to commence trading on The Nasdaq Capital Market on June 16, 2021 under ticker symbol "RSLS"Combination creates opportunity for ReShape to expand portfolio of FDA app
DGAP-News: ReShape Lifesciences Inc.: ReShape Lifesciences Completes Merger with Obalon Therapeutics 2021/06/16 11:30:01 Wallstreet:Online
DGAP-News: ReShape Lifesciences Inc. / Key word(s): Merger ReShape Lifesciences Inc.: ReShape Lifesciences Completes Merger with Obalon Therapeutics 16.06.2021 / 13:30 The issuer is solely responsible for the content of this announcement. ReShape Lifesciences Completes Merger with Obalon Therapeutics
ReShape Lifesciences Completes Merger with Obalon Therapeutics 2021/06/16 11:30:00 Wallstreet:Online
Shares of ReShape Lifesciences to commence trading on The Nasdaq Capital Market on June 16, 2021 under ticker symbol "RSLS"Combination creates opportunity for ReShape to expand portfolio of FDA approved weight loss solutions and reimbursed virtual
Active Stock Evaluation: Luokung Technology Corp. (NASDAQ:LKCO), Obalon Therapeutics, Inc. (NASDAQ:OBLN) 2021/06/23 20:57:02 Stock Equity
Luokung Technology Corp. (NASDAQ:LKCO) with the stream of 5.53% also noticed, India Obalon Therapeutics, Inc. (NASDAQ:OBLN) encountered a rapid change of 0.00% in the last hour of Wednesdays trading session. The post Active Stock Evaluation: Luokung Technology Corp. (NASDAQ:LKCO), Obalon Therapeutics, Inc. (NASDAQ:OBLN) appeared first on Stocks Equity .
ReShape Lifesciences (RSLS.Q) Completes Merger with Obalon Therapeutics 2021/06/16 17:46:19 Equity Guru
ReShape Lifesciences (RSLS.Q), a global weight-loss solutions leaders, announced today that it has completed its previously announced merger with Obalon Therapeutics, a vertically integrated medical technology company focused on developing and marketing medical devices. As a Nasdaq listed company, ReShape is poised to take advantage of the numerous benefits that accompany this new status, including [] The post ReShape Lifesciences (RSLS.Q) Completes Merger with Obalon Therapeutics appeared first on Equity.Guru .
ReShape Lifesciences Inc.: ReShape Lifesciences Completes Merger with Obalon Therapeutics 2021/06/16 11:32:00 FinanzNachrichten
Shares of ReShape Lifesciences to commence trading on The Nasdaq Capital Market on June 16, 2021 under ticker symbol "RSLS"Combination creates opportunity for ReShape to expand portfolio of FDA app
DGAP-News: ReShape Lifesciences Inc.: ReShape Lifesciences Completes Merger with Obalon Therapeutics 2021/06/16 11:30:01 Wallstreet:Online
DGAP-News: ReShape Lifesciences Inc. / Key word(s): Merger ReShape Lifesciences Inc.: ReShape Lifesciences Completes Merger with Obalon Therapeutics 16.06.2021 / 13:30 The issuer is solely responsible for the content of this announcement. ReShape Lifesciences Completes Merger with Obalon Therapeutics
ReShape Lifesciences Completes Merger with Obalon Therapeutics 2021/06/16 11:30:00 Wallstreet:Online
Shares of ReShape Lifesciences to commence trading on The Nasdaq Capital Market on June 16, 2021 under ticker symbol "RSLS"Combination creates opportunity for ReShape to expand portfolio of FDA approved weight loss solutions and reimbursed virtual
Active Stock Evaluation: Luokung Technology Corp. (NASDAQ:LKCO), Obalon Therapeutics, Inc. (NASDAQ:OBLN) 2021/06/23 20:57:02 Stock Equity
Luokung Technology Corp. (NASDAQ:LKCO) with the stream of 5.53% also noticed, India Obalon Therapeutics, Inc. (NASDAQ:OBLN) encountered a rapid change of 0.00% in the last hour of Wednesdays trading session. The post Active Stock Evaluation: Luokung Technology Corp. (NASDAQ:LKCO), Obalon Therapeutics, Inc. (NASDAQ:OBLN) appeared first on Stocks Equity .
ReShape Lifesciences (RSLS.Q) Completes Merger with Obalon Therapeutics 2021/06/16 17:46:19 Equity Guru
ReShape Lifesciences (RSLS.Q), a global weight-loss solutions leaders, announced today that it has completed its previously announced merger with Obalon Therapeutics, a vertically integrated medical technology company focused on developing and marketing medical devices. As a Nasdaq listed company, ReShape is poised to take advantage of the numerous benefits that accompany this new status, including [] The post ReShape Lifesciences (RSLS.Q) Completes Merger with Obalon Therapeutics appeared first on Equity.Guru .
ReShape Lifesciences Inc.: ReShape Lifesciences Completes Merger with Obalon Therapeutics 2021/06/16 11:32:00 FinanzNachrichten
Shares of ReShape Lifesciences to commence trading on The Nasdaq Capital Market on June 16, 2021 under ticker symbol "RSLS"Combination creates opportunity for ReShape to expand portfolio of FDA app
DGAP-News: ReShape Lifesciences Inc.: ReShape Lifesciences Completes Merger with Obalon Therapeutics 2021/06/16 11:30:01 Wallstreet:Online
DGAP-News: ReShape Lifesciences Inc. / Key word(s): Merger ReShape Lifesciences Inc.: ReShape Lifesciences Completes Merger with Obalon Therapeutics 16.06.2021 / 13:30 The issuer is solely responsible for the content of this announcement. ReShape Lifesciences Completes Merger with Obalon Therapeutics
ReShape Lifesciences Completes Merger with Obalon Therapeutics 2021/06/16 11:30:00 Wallstreet:Online
Shares of ReShape Lifesciences to commence trading on The Nasdaq Capital Market on June 16, 2021 under ticker symbol "RSLS"Combination creates opportunity for ReShape to expand portfolio of FDA approved weight loss solutions and reimbursed virtual